bf/NASDAQ:OCUL_icon.jpeg

NASDAQ:OCUL

Ocular Therapeutix, Inc.

  • Stock

USD

Last Close

6.27

17/05 20:00

Market Cap

513.62M

Beta: 1.30

Volume Today

1.17M

Avg: 1.63M

PE Ratio

−5.67

PFCF: −7.52

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
772K
-
1.75M
126.68%
1.89M
7.83%
1.92M
1.91%
1.99M
3.48%
4.23M
112.41%
17.40M
311.71%
43.52M
150.08%
51.49M
18.32%
58.44M
13.49%
cost of revenue
91K
-
319K
250.55%
443K
38.87%
457K
3.16%
465K
1.75%
2.33M
400%
2.08M
10.41%
4.41M
111.52%
4.54M
3.04%
5.28M
16.32%
gross profit
681K
-
1.43M
110.13%
1.44M
0.91%
1.47M
1.52%
1.52M
4.02%
1.90M
24.72%
15.32M
705.47%
39.12M
155.33%
46.95M
20.04%
53.16M
13.22%
selling and marketing expenses
625K
-
1.98M
217.12%
3.85M
94.35%
6.70M
73.96%
17M
153.69%
4.94M
70.93%
24.49M
395.57%
26.61M
8.67%
35.19M
32.22%
39.92M
13.45%
4.83M
87.91%
general and administrative expenses
1.76M
-
6.91M
292.56%
9.16M
32.58%
11.00M
20.07%
15.51M
40.94%
18.79M
21.13%
22.12M
17.76%
22.86M
3.33%
31.88M
39.46%
32.22M
1.08%
69.66M
116.18%
selling general and administrative expenses
2.39M
-
8.89M
272.80%
13.02M
46.34%
17.70M
36.01%
32.51M
83.61%
23.73M
27.01%
46.61M
96.45%
49.47M
6.14%
67.07M
35.57%
72.15M
7.57%
74.49M
3.25%
research and development expenses
10.52M
-
18.88M
79.52%
26.61M
40.95%
27.07M
1.71%
30.88M
14.10%
36.91M
19.54%
41.09M
11.31%
28.69M
30.17%
50.08M
74.54%
53.46M
6.75%
61.05M
14.20%
other expenses
14K
-
-442K
3,257.14%
7K
101.58%
-1K
114.29%
5K
600%
-8K
-
1K
-
-1K
200%
-1K
0%
cost and expenses
12.90M
-
27.87M
115.97%
39.95M
43.35%
45.21M
13.18%
63.85M
41.21%
61.11M
4.29%
90.03M
47.33%
80.25M
10.86%
121.56M
51.48%
130.15M
7.07%
140.82M
8.20%
operating expenses
12.90M
-
27.77M
115.26%
39.63M
42.68%
44.77M
12.98%
63.39M
41.59%
60.64M
4.33%
87.70M
44.62%
78.17M
10.87%
117.15M
49.88%
125.61M
7.22%
135.54M
7.91%
interest expense
441K
-
1.12M
153.74%
1.72M
54.07%
1.68M
2.55%
1.89M
12.62%
1.74M
8.09%
6.10M
250.83%
6.77M
10.93%
6.67M
1.43%
7.02M
5.26%
11.34M
61.46%
ebitda
-12.47M
-
-27.53M
120.73%
-38.02M
38.12%
-43.02M
13.15%
-61.49M
42.93%
-58.24M
5.29%
-84.58M
45.23%
-62.68M
25.89%
-78.00M
24.45%
-77.86M
0.19%
-79.40M
1.98%
operating income
-12.90M
-
-27.09M
109.98%
-38.20M
40.98%
-43.33M
13.43%
-61.92M
42.92%
-59.12M
4.53%
-85.80M
45.14%
-62.85M
26.75%
-78.04M
24.17%
-78.65M
0.79%
-82.38M
4.74%
depreciation and amortization
404K
-
547K
35.40%
754K
37.84%
881K
16.84%
1.63M
84.45%
879K
45.91%
1.22M
38.91%
168K
86.24%
34K
79.76%
797K
2,244.12%
2.98M
274.28%
total other income expenses net
14K
-
-442K
3,257.14%
7K
101.58%
-1K
114.29%
5K
600%
-860K
17,300%
-570K
33.72%
-92.79M
16,178.77%
71.48M
177.04%
7.62M
89.35%
1.65M
78.39%
income before tax
-13.32M
-
-28.65M
115.12%
-39.75M
38.75%
-44.70M
12.47%
-63.39M
41.79%
-59.98M
5.38%
-86.37M
44.01%
-155.64M
80.19%
-6.55M
95.79%
-71.04M
984.05%
-80.74M
13.65%
income tax expense
455K
-
130K
71.43%
977K
651.54%
798K
18.32%
272K
65.91%
-2.29M
940.44%
3.56M
255.86%
4.00M
12.12%
4.25M
6.41%
-7.62M
279.16%
net income
-13.32M
-
-28.65M
115.12%
-39.75M
38.75%
-44.70M
12.47%
-63.39M
41.79%
-57.69M
8.98%
-89.94M
55.89%
-159.63M
77.50%
-10.80M
93.23%
-63.42M
487.02%
-80.74M
27.30%
weighted average shs out
2.95M
-
10.65M
260.79%
23.24M
118.20%
24.82M
6.76%
28.82M
16.13%
38.12M
32.26%
45.27M
18.78%
60.75M
34.19%
76.39M
25.74%
76.88M
0.63%
79.83M
3.84%
weighted average shs out dil
2.95M
-
10.65M
260.79%
23.24M
118.20%
24.82M
6.76%
28.82M
16.13%
38.12M
32.26%
45.27M
18.78%
60.75M
34.19%
82.16M
35.24%
76.88M
6.43%
85.60M
11.35%
eps
-4.51
-
-2.69
40.35%
-1.71
36.43%
-1.80
5.26%
-2.20
22.22%
-1.51
31.36%
-1.99
31.79%
-2.63
32.16%
-0.14
94.68%
-0.83
492.86%
-1.01
21.69%
epsdiluted
-4.51
-
-2.69
40.35%
-1.71
36.43%
-1.80
5.26%
-2.20
22.22%
-1.51
31.36%
-1.99
31.79%
-2.63
32.16%
-0.13
95.06%
-0.83
538.46%
-0.94
13.25%

All numbers in USD (except ratios and percentages)